Literature DB >> 27324234

Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.

L P Li1, F F Song1, Y Y Weng1, X Yang1, K Wang1, H M Lei1, J Ma2, H Zhou1, H D Jiang1.   

Abstract

BACKGROUND AND
PURPOSE: Nitidine chloride (NC), a benzophenanthridine alkaloid, has various biological properties including anticancer and analgesic activities. The aim of the present study was to evaluate the role of organic cation transporter 2 (OCT2) and multidrug and toxin extrusion 1 (MATE1) in the renal disposition and nephrotoxicity of NC. EXPERIMENTAL APPROACH: MDCK cells stably expressing human OCT2 and/or hMATE1 were used to investigate the OCT2- and MATE1-mediated transport of NC. In addition, the accumulation of NC and its potential toxicity were studied in rat primary-cultured proximal tubular (rPCPT) cells and in rats in vivo. KEY
RESULTS: NC was found to be a high-affinity substrate of both OCT2 and MATE1 with high cytotoxicity in MDCK-hOCT2/hMATE1 and MDCK-hOCT2 compared to mock cells. The OCT2 inhibitors, cimetidine and (+)-tetrahydropalmatine ((+)-THP), significantly reduced NC accumulation and cytotoxicity in MDCK-hOCT2, MDCK-hOCT2/hMATE1 and rPCPT cells. Severe kidney damage with high levels of blood urea nitrogen and lactate dehydrogenase (LDH), reduced levels of alkaline phosphatase (ALP) and pathological changes were found in rats after 20 days of successive i.v. doses of NC (5 mg·kg(-1) ·day(-1) ). Concomitantly, the concentration of NC in the kidney reached similar high levels at 2 h after the last dose of the 20 day treatment as those observed at 0.5 h after a single i.v. dose of 5 mg·kg(-1) . CONCLUSIONS AND IMPLICATIONS: Our data indicate that NC-induced nephrotoxicity might be mainly attributed to OCT2-mediated extensive renal uptake and weak tubular secretion by MATE1.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27324234      PMCID: PMC4959954          DOI: 10.1111/bph.13537

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.

Authors:  Fabian Müller; Jörg König; Hartmut Glaeser; Ingrid Schmidt; Oliver Zolk; Martin F Fromm; Renke Maas
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway.

Authors:  Xinhua Pan; Honghui Han; Lei Wang; Linli Yang; Ruimei Li; Zhenxi Li; Junchen Liu; Qufei Zhao; Min Qian; Mingyao Liu; Bing Du
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

3.  Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.

Authors:  Hideyuki Motohashi; Yumi Nakao; Satohiro Masuda; Toshiya Katsura; Tomomi Kamba; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Pharm Sci       Date:  2013-04-29       Impact factor: 3.534

4.  Potent antimalarial activity of the alkaloid nitidine, isolated from a Kenyan herbal remedy.

Authors:  D M Gakunju; E K Mberu; S F Dossaji; A I Gray; R D Waigh; P G Waterman; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

5.  Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.

Authors:  J A Holden; M E Wall; M C Wani; G Manikumar
Journal:  Arch Biochem Biophys       Date:  1999-10-01       Impact factor: 4.013

6.  TRAF6 knockdown promotes survival and inhibits inflammatory response to lipopolysaccharides in rat primary renal proximal tubule cells.

Authors:  S Liu; J Lutz; J Chang; D Liu; U Heemann; M Baumann
Journal:  Acta Physiol (Oxf)       Date:  2010-02-05       Impact factor: 6.311

7.  The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity.

Authors:  Liping Li; Meijuan Tu; Xi Yang; Siyuan Sun; Xiaodan Wu; Hui Zhou; Su Zeng; Huidi Jiang
Journal:  Drug Metab Dispos       Date:  2014-04-28       Impact factor: 3.922

8.  Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures.

Authors:  Adam N Elwi; Vijaya L Damaraju; Michelle L Kuzma; Stephen A Baldwin; James D Young; Michael B Sawyer; Carol E Cass
Journal:  Cancer Chemother Pharmacol       Date:  2008-05-24       Impact factor: 3.333

Review 9.  In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

10.  Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.

Authors:  Yue-Ping Liu; Hai-Yan Wu; Xiang Yang; Han-Qing Xu; Yong-Chuan Li; Da-Chuan Shi; Jun-Fu Huang; Qing Huang; Wei-Ling Fu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

View more
  13 in total

1.  Protective effect of cilastatin against diclofenac-induced nephrotoxicity through interaction with diclofenac acyl glucuronide via organic anion transporters.

Authors:  Xiaokui Huo; Qiang Meng; Changyuan Wang; Jingjing Wu; Chong Wang; Yanna Zhu; Xiaodong Ma; Huijun Sun; Kexin Liu
Journal:  Br J Pharmacol       Date:  2020-03-05       Impact factor: 8.739

2.  Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.

Authors:  L P Li; F F Song; Y Y Weng; X Yang; K Wang; H M Lei; J Ma; H Zhou; H D Jiang
Journal:  Br J Pharmacol       Date:  2016-07-09       Impact factor: 8.739

3.  Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy.

Authors:  Zhiyuan Ma; Shuanghui Lu; Dongli Sun; Mengru Bai; Ting Jiang; Nengming Lin; Hui Zhou; Su Zeng; Huidi Jiang
Journal:  Br J Pharmacol       Date:  2019-07-10       Impact factor: 8.739

4.  Changes of renal transporters in the kinetic process of VCM-induced nephrotoxicity in mice.

Authors:  Hongjing Li; Qiaoling Yang; Mingzhu Gui; Lili Ding; Li Yang; Huajun Sun; Zhiling Li
Journal:  Toxicol Res (Camb)       Date:  2021-06-09       Impact factor: 2.680

5.  Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs).

Authors:  Xiaokui Huo; Qiang Meng; Changyuan Wang; Yanna Zhu; Zhihao Liu; Xiaodong Ma; Xiaochi Ma; Jinyong Peng; Huijun Sun; Kexin Liu
Journal:  Acta Pharm Sin B       Date:  2019-02-18       Impact factor: 11.413

6.  Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma.

Authors:  Danni Li; Shaogang Liu; Jiahao Zhu; Liqun Shen; Qi Ying Zhang; Hua Zhu
Journal:  BMC Pharmacol Toxicol       Date:  2021-01-06       Impact factor: 2.483

7.  Upregulation of lncRNA NONRATG019935.2 suppresses the p53-mediated apoptosis of renal tubular epithelial cells in septic acute kidney injury.

Authors:  Ying Ding; Dao-Yang Zhou; Hong Yu; Tao Zhu; Feng Guo; Yang He; Xiu-Liu Guo; Yong-Jun Lin; Yu-Jiao Liu; Yun-Song Yu
Journal:  Cell Death Dis       Date:  2021-11-01       Impact factor: 8.469

Review 8.  A Comprehensive Review on the Chemical Properties, Plant Sources, Pharmacological Activities, Pharmacokinetic and Toxicological Characteristics of Tetrahydropalmatine.

Authors:  Qinyun Du; Xianli Meng; Shaohui Wang
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

Review 9.  Natural products targeting cancer cell dependency.

Authors:  Changxiang Shi; Eun Ju Yang; Shishi Tao; Guowen Ren; Pui Kei Mou; Joong Sup Shim
Journal:  J Antibiot (Tokyo)       Date:  2021-06-23       Impact factor: 2.649

10.  Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SAR, Molecular Docking, and ADMET Analyses.

Authors:  Nahed N E El-Sayed; Taghreed M Al-Otaibi; Mona Alonazi; Vijay H Masand; Assem Barakat; Zainab M Almarhoon; Abir Ben Bacha
Journal:  Molecules       Date:  2021-05-23       Impact factor: 4.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.